Destiny Pharma PLC Total Voting Rights (5084A)
29 December 2017 - 6:00PM
UK Regulatory
TIDMDEST
RNS Number : 5084A
Destiny Pharma PLC
29 December 2017
Destiny Pharma plc
("Destiny Pharma" or "the Company")
Total Voting Rights
As a result of the issue of 1,910,828 shares at GBP1.57 each to
China Medical Venture Investments, which raised GBP3 million for
the Company, and which was announced on 1 December 2017, the
Company announces that, pursuant to Rule 5.6.1 of the FCA's
Disclosure Guidance and Transparency Rules, the total number of
ordinary shares in issue now stands at 43,562,598, and the total
number of voting rights in the Company is 43,562,598.
The above figure may be used by shareholders as the denominator
for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest
in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
For further information, please contact:
Destiny Pharma
Neil Clark, CEO
Simon Sacerdoti, CFO
pressoffice@destinypharma.com
+44 (0)1273 704 440
FTI Consulting
Simon Conway / Victoria Foster Mitchell / Hanna Skeppner
destinypharma@fticonsulting.com
+44 (0) 20 3727 1000
Cantor Fitzgerald Europe (Nominated Adviser and Broker)
Philip Davies / Will Goode, Corporate Finance
pdavies@cantor.co.uk
+44 (0)20 7894 8337
About Destiny Pharma
Destiny Pharma is an established, clinical stage, innovative
biotechnology company focused on the development of novel medicines
that represent a new approach to the treatment of infectious
disease. These potential new medicines are being developed to
address the need for new drugs for the prevention and treatment of
life-threatening infections caused by antibiotic-resistant
bacteria, often referred to as "superbugs". Tackling anti-microbial
resistance has become a global imperative recognised by the WHO and
the United Nations, as well as the G7 and the G20 countries. For
further information, please visit https://www.destinypharma.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
TVRDMMZZVRLGNZM
(END) Dow Jones Newswires
December 29, 2017 02:00 ET (07:00 GMT)
Destiny Pharma (LSE:DEST)
Historical Stock Chart
From Apr 2024 to May 2024
Destiny Pharma (LSE:DEST)
Historical Stock Chart
From May 2023 to May 2024